• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles names Hospital Italiano first Latin American Prime Site

Quintiles names Hospital Italiano first Latin American Prime Site

April 16, 2015
CenterWatch Staff

Global CRO Quintiles has named Hospital Italiano of Buenos Aires, Argentina, as its first Prime Site in Latin America.

Quintiles said the institution complements its network of investigative sites across the globe. A Prime Site is a large clinical institution selected by Quintiles, with which it works to enhance the institution’s infrastructure for conducting clinical trials. Quintiles and its Prime Sites work together to create a more efficient clinical trial process by recruiting, enrolling and retaining more patients through the course of a clinical trial.

The agreement with Hospital Italiano is designed to involve more patients in clinical trials than previously has been possible in one location in Latin America, increasing patient access to medications. Ultimately, this agreement will help accelerate the collection of critical data about the safety and efficacy of investigational therapies. 

“According to the Tufts Center for the Study of Drug Development, timelines are typically extended to nearly double their original duration to meet desired patient enrolment levels across all therapeutic areas—delays that can increase costs, deplete resources and prolong the time it takes for drugs to get to patients in need,” said Jeanne Hecht, senior vice president of site and patient networks at Quintiles. “Quintiles recognizes these challenges and is dedicated to working together differently across the healthcare system to transform drug development and achieve better patient outcomes.”

The new Prime Site at Hospital Italiano has dedicated research facilities, full-time study coordinators, a local College of American Pathologists (CAP)-accredited laboratory and full-service pharmacy. To date, Hospital Italiano has conducted more than 60 trials in 12 different therapeutic areas with Quintiles—comparable to other Quintiles Prime Sites—and has delivered the required patients for a variety of complex trials for the CRO.

“Hospital Italiano is founded upon three core tenets: healthcare, education and research,” said Dr. Ventura Simonovich, clinical operations coordinator at Hospital Italiano.

Key to the success of the Prime Site program, said Quintiles, are its efforts to harmonize operational processes, drive efficiencies in site startup and build better relationships with site staff, which, in turn, supports patient recruitment.

As increasingly complex clinical trials pose more barriers for effective patient recruitment, Quintiles is combining the power of the digitally-connected patient with its scientific and therapeutic expertise to connect the right patients with the right sites at the right time. For instance, the company is developing pre-profiled patient networks and leveraging Electronic Health Record data analytics representing more than 61 million patient lives to provide pre-qualified patient referrals to sites for specific studies. In addition, Quintiles hosts a series of online communities with more than 3.5 million registered users that provide the company with unique insights to enhance its patient recruitment strategies.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing